- Home
- SHPH vs NUWE Comparison
SHPH vs NUWE Comparison
Compare SHPH & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHPH
- NUWE
- Stock Information
- Founded
- SHPH 2012
- NUWE 1999
- Country
- SHPH United States
- NUWE United States
- Employees
- SHPH N/A
- NUWE N/A
- Industry
- SHPH Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SHPH Health Care
- NUWE Health Care
- Exchange
- SHPH Nasdaq
- NUWE Nasdaq
- Market Cap
- SHPH 3.2M
- NUWE 2.9M
- IPO Year
- SHPH 2022
- NUWE N/A
- Fundamental
- Price
- SHPH $2.55
- NUWE $2.71
- Analyst Decision
- SHPH
- NUWE
- Analyst Count
- SHPH 0
- NUWE 0
- Target Price
- SHPH N/A
- NUWE N/A
- AVG Volume (30 Days)
- SHPH 356.7K
- NUWE 124.9K
- Earning Date
- SHPH 11-13-2025
- NUWE 11-12-2025
- Dividend Yield
- SHPH N/A
- NUWE N/A
- EPS Growth
- SHPH N/A
- NUWE N/A
- EPS
- SHPH N/A
- NUWE N/A
- Revenue
- SHPH N/A
- NUWE $8,318,000.00
- Revenue This Year
- SHPH N/A
- NUWE $6.53
- Revenue Next Year
- SHPH N/A
- NUWE $51.63
- P/E Ratio
- SHPH N/A
- NUWE N/A
- Revenue Growth
- SHPH N/A
- NUWE N/A
- 52 Week Low
- SHPH $2.25
- NUWE $2.60
- 52 Week High
- SHPH $30.84
- NUWE $107.94
- Technical
- Relative Strength Index (RSI)
- SHPH 32.85
- NUWE 38.15
- Support Level
- SHPH $2.25
- NUWE $2.60
- Resistance Level
- SHPH $3.56
- NUWE $2.93
- Average True Range (ATR)
- SHPH 0.22
- NUWE 0.27
- MACD
- SHPH -0.06
- NUWE -0.01
- Stochastic Oscillator
- SHPH 21.64
- NUWE 7.14
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.